Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Neuroone Medical Technologies Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q3 2023
- Shares held
- 4.31M
- +144.7K (+3.5%) vs. Q3 2023
- Total value
- $6.81M
- +$3.10M (+83.6%) vs. Q3 2023
- New holders
- 4
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.21M |
| Q1 2026 | 32 | $9.14M |
| Q4 2025 | 37 | $9.44M |
| Q3 2025 | 34 | $12.8M |
| Q2 2025 | 31 | $9.80M |
| Q1 2025 | 19 | $2.63M |
| Q4 2024 | 21 | $2.30M |
| Q3 2024 | 22 | $3.59M |
| Q2 2024 | 19 | $2.95M |
| Q1 2024 | 19 | $5.16M |
| Q4 2023 | 21 | $6.81M |
| Q3 2023 | 20 | $3.71M |
| Q2 2023 | 15 | $1.79M |
| Q1 2023 | 16 | $2.44M |
| Q4 2022 | 21 | $1.53M |
| Q3 2022 | 12 | $2.99M |
| Q2 2022 | 11 | $1.51M |
| Q1 2022 | 12 | $2.33M |
| Q4 2021 | 17 | $6.52M |
| Q3 2021 | 9 | $4.94M |
| Q2 2021 | 4 | $9.36M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Neuroone Medical Technologies Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 30 | $48 | 0.00% | −70−70.0% | Reduced |
| JPMorgan Chase & Co | 39 | $62 | 0.00% | +13+50.0% | Added |
| Wells Fargo & Company | 175 | $277 | 0.00% | +9+5.4% | Added |
| Advisor Group Holdings, Inc. | 350 | $553 | 0.00% | −350−50.0% | Reduced |
| Nemes Rush Group LLC | 433 | $685 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,885 | $2.98K | 0.00% | +1,777+1,645.4% | Added |
| Simplex Trading, LLC | 2,920 | $4.00K | 0.00% | +2,895+11,580.0% | Added |
| Centerpoint Advisors, LLC | 5,000 | $8.00K | 0.00% | +5,000 | New |
| Tower Research Capital LLC (TRC) | 5,137 | $8.12K | 0.00% | +5,137 | New |
| Princeton Global Asset Management LLC | 16,833 | $26.6K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 18,117 | $29.0K | 0.00% | +18,117 | New |
| Wealth Alliance Advisory Group, LLC | 19,500 | $30.8K | 0.01% | +19,500 | New |
| Northern Trust Corp | 30,281 | $47.8K | 0.00% | +10,348+51.9% | Added |
| MAI Capital Management | 50,000 | $79.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 51,599 | $81.5K | 0.00% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 150,000 | $237.0K | 0.20% | 00.0% | Unchanged |
| Mayo Clinic | 181,754 | $287.2K | 1.77% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 197,121 | $311.5K | 0.00% | +18,859+10.6% | Added |
| Vanguard Group Inc | 917,630 | $1.45M | 0.00% | +478,149+108.8% | Added |
| Nantahala Capital Management, LLC | 1,214,094 | $1.92M | 0.19% | −35,906−2.9% | Reduced |
| AWM Investment Company, Inc. | 1,450,000 | $2.29M | 0.30% | −100,000−6.5% | Reduced |
| Walleye Capital LLC | 0 | $0 | 0.00% | −225,956−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −50,453−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |